DCM
NEO icon

Dupont Capital Management’s NeoGenomics NEO Stock Holding History

Dupont Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,996
Closed -$138K – 1487
2022
Q3 		$138K Buy
+15,996
New +$159K 0.01% 953
2021
Q2 		– Sell
-14,121
Closed -$681K – 1794
2021
Q1 		$681K Sell
14,121
-2,897
-17% -$151K 0.02% 786
2020
Q4 		$916K Buy
17,018
+5,457
+47% +$247K 0.02% 593
2020
Q3 		$426K Buy
11,561
+3,566
+45% +$133K 0.01% 823
2020
Q2 		$248K Buy
+7,995
New +$222K 0.01% 1047

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dupont Capital Management's NEO Position: Q4 2022 in Review

Dupont Capital Management sold out of NeoGenomics (NEO) in Q4 2022, closing a stake of 15,996 shares — an estimated $138K sold.

Dupont Capital Management first reported a position in NEO in Q2 2020 and held it in 5 quarters. The position peaked at $916K in Q4 2020. 242 funds tracked by Wall St. Rank hold NEO as of Q4 2022.

  • Dupont Capital Management reported no remaining NeoGenomics position as of Q4 2022 after selling out during the quarter.
  • Dupont Capital Management sold 15,996 NeoGenomics shares in Q4 2022, an estimated $138K.
  • Dupont Capital Management first reported a position in NeoGenomics in Q2 2020 and held it in 5 quarters.
  • Dupont Capital Management's NeoGenomics position peaked at $916K in Q4 2020.
  • 242 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.